We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi Says Mylan Infringing 18 Insulin Patents

Law360, New York (October 26, 2017, 3:33 PM EDT) -- Sanofi filed a patent infringement suit Tuesday in New Jersey federal court alleging Mylan’s planned generic version of Sanofi’s insulin pen, Lantus, infringes 18 of its patents.

Sanofi said in the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.